Obstetrics
Conference Coverage
Metformin improves most outcomes for T2D during pregnancy
But the drug was associated with an increased risk of small-for-gestational-age babies.
From the Journals
Pregnancy outcomes ‘favorable’ after BRCA breast cancer treatment
Pregnancy after treatment for breast cancer with BRCA mutations is safe, researchers say.
Conference Coverage
Report may inform first dietary guidelines for Americans from birth to 24 months
The USDA and HHS aim to release new dietary guidelines by the end of the year with recommendations for infants, toddlers, and women who are...
From the Journals
Fertility delay varied with contraceptive method in study
Users of injectable contraceptives had a delay of up to 8 months after discontinuing before they conceived.
Expert Commentary
Employment protections now include sexual orientation, but our role in LGBTQIA+ equality continues
Advocacy Column
[title]
A SCOTUS ruling signals optimism for the LGBTQIA+ community; however, the...
Sponsored Supplement
Is Routine 39-Week Induction of Labor in Healthy Pregnancy a Reasonable Course?
Conference Coverage
Pregnancy can be safe with interstitial lung disease
Often women with ILD related to an autoimmune disease are advised to avoid conception or terminate their pregnancies. But the largest study to...
From the Journals
COVID-19 in pregnancy raises risk of preterm birth and severe disease
Early data support counseling pregnant women about risks for severe illness associated with infection.
From the Journals
New case suggestive of in utero SARS-CoV-2 transmission
In this rare case of transmission of SARS-CoV-2 from a mother to her neonate, virus was detected in cord blood but not placenta.
From the Journals
Primary care workforce expanding, but mostly in cities
The number of nurse practitioners and physician assistants has increased much faster than the number of primary care physicians.
From the Journals
Proposed withdrawal of approval of preterm drug: Two opposing views
This move was sparked when Amag Pharmaceuticals’ 17OHP, Makena, failed to show benefit in a postmarketing confirmatory trial.
Commentary
Maternal oxygen in labor:
False reassurance?
These experts offer evidence for why ObGyns should stop the liberal use of maternal oxygenation to manage abnormal FHR tracings